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Dietary polyphenols are suggested to participate in the prevention of CVD and cancer. It is essential for epidemiological studies to be able to compare intake
of the main dietary polyphenols in populations. The present paper describes a fast method suitable for the analysis of polyphenols in urine, selected as
potential biomarkers of intake. This method is applied to the estimation of polyphenol recovery after ingestion of six different polyphenol-rich beverages.
Fifteen polyphenols including mammalian lignans (enterodiol and enterolactone), several phenolic acids (chlorogenic, caffeic, m-coumaric, gallic, and 4-O-
methylgallic acids), phloretin and various flavonoids (catechin, epicatechin, quercetin, isorhamnetin, kaempferol, hesperetin, and naringenin) were simul-
taneously quantified in human urine by HPLC coupled with electrospray ionisation mass-MS (HPLC-electrospray-tandem mass spectrometry) with a run
time of 6 min per sample. The method has been validated with regard to linearity, precision, and accuracy in intra- and inter-day assays. It was applied
to urine samples collected from nine volunteers in the 24 h following consumption of either green tea, a grape-skin extract, cocoa beverage, coffee, grape-
fruit juice or orange juice. Levels of urinary excretion suggest that chlorogenic acid, gallic acid, epicatechin, naringenin or hesperetin could be used as
specific biomarkers to evaluate the consumption of coffee, wine, tea or cocoa, and citrus juices respectively.
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The relationship between the diet and prevention of diseases in
man has been the topic of numerous investigations during
recent years. A reduction of disease risk has been attributed to
antioxidants present in foods, due to their ability to scavenge
free radicals and thus reduce oxidative damage (Gutteridge &
Halliwell, 1994). Polyphenols are the most abundant antioxidants
in our diets (Scalbert & Williamson, 2000) and their consumption
may contribute to prevent cancers, stroke, CHD, neurodegenera-
tive diseases or diabetes (Scalbert et al. 2005). Polyphenols are
found in many foods of plant origin and are particularly abundant
in fruits and beverages such as tea, wine or coffee. They form a
highly diverse class of compounds. They are distributed in several
categories according to their structures with phenolic acids, flavo-
noids and lignans being the most widespread in food (Shahidi &
Naczk, 2003). Their biological properties and bioavailability
depends on their chemical structure (Manach et al. 2004a,b)
and it is important to study the effects on health of the different
types of polyphenols. A number of epidemiological studies have
been carried out on some flavonoids (flavonols, flavones, flava-
nols and isoflavones) and lignans (Arts & Hollman, 2005).
These studies largely rely on the accurate estimation of polyphe-
nol intake or exposure. This estimation was most often based on
the use of food composition tables. Variations in isoflavone or
lignan intake have also been evaluated in case–control studies
through the measurement of their concentrations in urine or
plasma (Adlercreutz et al. 1982; Akaza et al. 2002; Hulten et al.
2002). The use of these biomarkers of exposure was validated in
free-living populations by a good correlation between urinary
excretion or serum concentration of polyphenols and the con-
sumption of polyphenol-rich foods such as soya (isoflavones),
whole grains (lignans) or fruit and vegetables (various flavonoids,
lignans) (Maskarinec et al. 1998; Lampe et al. 1999; Kilkkinen
et al. 2001; Nielsen et al. 2002).
The present study reports variations in the urinary excretion of
major dietary polyphenols after consumption of six polyphenol-
rich beverages. The recent developments of MS have made poss-
ible the current estimation of a wide range of polyphenols with
good sensitivity of analysis (Nielsen et al. 2000; Franke et al.
2002; Gonthier et al. 2003b). A high-throughput method for the
simultaneous quantification in human urine of fifteen polyphenols
and related compounds using the HPLC-electrospray-tandem
mass spectrometry (HPLC-ESI-MS-MS) method was developed
and applied to the measurement of polyphenol recovery in
urine. The short run time makes the method particularly adapted
to the analysis of large batches of samples in epidemiological
studies.
*Corresponding author: Dr Augustin Scalbert, fax þ33 4 73 62 46 38, email scalbert@clermont.inra.fr
Abbreviation: HPLC-ESI-MS-MS, HPLC-electrospray-tandem mass spectrometry.
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Materials and methods
Materials
Chlorogenic acid, caffeic acid, m-coumaric acid, gallic acid, cate-
chin, epicatechin, quercetin, kaempferol, hesperetin, naringenin,
phloretin, taxifolin, and type H-2 b-glucuronidase (G-0876)
from Helix pomatia were purchased from Sigma (St Louis, MO,
USA). Enterodiol and enterolactone were obtained from Fluka
(St Quentin Fallavier, France). 4-O-Methylgallic acid was pre-
pared by refluxing overnight a mixture of gallic acid, dimethyl
sulfate and potassium carbonate in dry acetone. The resulting
methyl ester was purified by preparative TLC and hydrolysed
with 5 % methanolic potassium hydroxide for 3 h to afford 4-O-
methylgallic acid, which was purified by column chromatography
over MCI-GEL CHP-20P (Mitsubishi, Tokyo, Japan).
Subjects
The study was approved by the ethical committee for human
experimentation of the University Hospital of Clermont-Ferrand,
France (ethics reference CCPPRB-AU362). Exclusion criteria
were as follows: signs of diseases related to the gastrointestinal
tract, any form of liver disease or gall bladder problems, use of
drugs that influenced gastrointestinal transit, present illness, preg-
nancy or lactation. Nine subjects (five women and four men), with
a mean age of 25 (SD 1) years (range 20–32 years), and a mean
BMI of 22·1 (SD 0·6) kg/m2 (range 18·9–24·8 kg/m2) were
admitted to participate and signed an informed consent form.
The subjects were healthy, based on a medical questionnaire,
had normal blood values for Hb, packed cell volume and leuco-
cyte counts, and absence of glucose and protein in urine. They
had stable food habits and were not vegetarians.
Polyphenol-rich beverages
The composition of polyphenol extracts used for beverage prep-
aration is detailed in Table 1. Decaffeinated coffee powder was
from the Nestle´ Product Technology Centre (Vevey, Switzerland).
Green tea extract was provided by Unilever Research (Colworth,
Beds, UK) and contained caffeine (14·1 mg/g). Cocoa powder was
from Mars, Inc. (Hackettstown, NJ, USA) and contained caffeine
(2·1 mg/g), theobromine (21·1 mg/g) and fat (106·3 mg/g). Grape
skin extract was from CHR Hansen (St-Julien-de-Peyrolas,
France). Grapefruit and orange juices (100 % pure juice) were
bought in a local supermarket. Phenolic composition was deter-
mined by HPLC by the suppliers of the materials. Flavanones
were determined by HPLC as previously described (Manach
et al. 2003).
Study design
Subjects followed a diet low in polyphenols for 2 d before the test
meal. To ensure adherence to the dietary guidelines, volunteers
were given a list of forbidden foods and beverages; fruits and
fruit-containing foods, vegetables, whole cereals, chocolate and
beverages rich in polyphenols (coffee, tea, fruit juice, cocoa
drinks, wine, cider, and beer) were excluded from the diet. Poly-
phenol-rich beverages were made of 4 g instant coffee (equivalent
to two cups of coffee), 0·3 g green tea extract (equivalent to one
cup of tea), 10 g cocoa powder (equivalent to one cup of hot cho-
colate) or 18 g grape-skin extract, dissolved in 200 ml hot water. T
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Quantities were determined in order to provide the equivalent of
250–290 mg polyphenols. On day 3, after an overnight fast, all
subjects consumed one of the polyphenol-rich beverages or hot
water as a control (200 ml) between 08.00 and 08.30 hours at
the laboratory, together with a breakfast that was provided. Break-
fast consisted of bread, butter and milk. After breakfast, subjects
stayed at the laboratory all day and were allowed to drink water
from 12.00 hours. They received a dinner without polyphenols
at 18.00 hours and were asked to continue the polyphenol-free
diet on day 4. All test meals were consumed once by each subject
in a randomised order at intervals of 14 d. Volunteers collected
24 h urine samples from breakfast time until the next day at the
same hour. Urine samples were stored at 4 8C and immediately
treated with sodium azide (1 g/l) and acidified to pH 4 with
HCl (40 mmol/l) on reception in the laboratory. Samples were
stored at 220 8C until analysis. Citrus juices were tested in a sep-
arate protocol. Nine male volunteers ingested after an overnight
fast 430 ml grapefruit juice and 1 week later 550 ml orange
juice. Urine was collected in different fractions (0–6, 6–12 and
12–24 h periods) from breakfast time until the following day in
plastic bottles containing 1 g ascorbic acid. Sodium azide (1 g/l)
was added at the end of each collection period. Samples of
urine were stored at 280 8C. Only the 6–12 h samples, corre-
sponding to the peak of flavanone excretion (Manach et al.
2003), were analysed.
Analysis of polyphenols in urine
Urine samples (250ml) were acidified with 0·58 M-acetic acid
(20ml) containing taxifolin (50mM) as internal standard and incu-
bated with 1300 units of b-glucuronidase and thirty-eight units of
sulfatase (from H. pomatia, Sigma G0876; Sigma, St Louis, MO,
USA) for 45 min at 37 8C. The duration of hydrolysis of 45 min
was selected as it is intermediate between optimal times for
different polyphenols present in the analysed samples (Morand
et al. 2001). After addition of 1 M-HCl (10ml), samples were
extracted twice with ethyl acetate (400 and 300ml), and centri-
fuged for 10 min at 5000 g. The combined organic layers were
evaporated under N2, re-dissolved by vortexing in 25 % aqueous
methanol (200ml), filtered (PTFE membrane, 0·45mm; Millipore,
Bedford, MA, USA) and injected (20ml) into the HPLC-ESI-MS-
MS system.
HPLC-ESI-MS-MS analysis was performed on a Hewlett-Pack-
ard 1100 HPLC system (Waldbronn, Germany) coupled to a triple
quadrupole mass spectrometer, API-2000 (Applied Biosystems,
Creemore, ON, Canada). The chromatographic column was a
Zorbax Eclipse XDB-C18 (internal diameter 2·1 £ 30 mm,
3·5mm, Agilent) maintained at 20 8C, and the mobile phase con-
sisted of water–formic acid (100:0·1, v/v) (solvent A) and aceto-
nitrile–water–formic acid (95:5:0·1, by vol.) (solvent B). A
gradient was applied as follows: the proportion of solvent B in
the eluent increased from 0 % to 10 % (t ¼ 1 min), 100 %
(t ¼ 4 min) and decreased back to 0 % (t ¼ 4·1 min) until the
next injection (t ¼ 6 min). The flow rate was 0·8 ml/min with
0·2 ml/min split directed to the mass spectrometer. Mass detection
was carried out in multiple reaction monitoring mode using an
electrospray interface operating in negative-ion mode at 450 8C
with nebuliser pressure of 90 pounds per square inch, a drying
N2 gas flow of 11 litres/min, a fragmentor voltage of 20 V and
capillary voltage of 4000 V. Ionisation and fragmentation was
optimised for each polyphenol by direct infusion of a standard
solution (five parts per million in 40 % aqueous CH3CN contain-
ing 0·1 % formic acid solution). Parent and product ions are given
in Table 2. Two acquisition periods were defined for each analysis
with dwell times of 170 ms for the first period and 85 ms for the
second period. Peak identity was established by both the charac-
teristic parent and product ion pair and retention time.
Calibration curves and limits of detection and quantification
Calibration curves were prepared by spiking blank urine with
samples of standard mixture solutions at different concentrations
with duplicate injections at each level. Different blank urine
samples were compared by checking for the absence of any sig-
nificant ion suppression effect. Spiked urine samples were treated
with enzymes and extracted with ethyl acetate as earlier. The fol-
lowing concentration ranges were validated: 0·5–5mM for chloro-
genic, caffeic and m-coumaric acids, quercetin, kaempferol,
Table 2. Parent and product ions, retention time, and limits of detection and quantification of polyphenols, their metabolites and
internal standard
Compound Parent ion (m/z) Product ion (m/z) Retention time (min) LOD (mM) LOQ (mM)
Chlorogenic acid 353 191 2·53 0·2 1
Caffeic acid 179 135 2·56 0·01 0·05
m-Coumaric acid 163 119 2·95 0·01 0·05
Gallic acid 169 125 0·43 0·5 1
4-O-Methylgallic acid 183 124 2·22 0·5 1
Catechin 289 109 2·51 1 5
Epicatechin 289 109 2·71 1 5
Quercetin 301 151 3·33 0·1 0·5
Isorhamnetin 315 300 3·52 0·05 0·2
Kaempferol 285 93 3·49 1 5
Hesperetin 301 164 3·50 0·2 1
Naringenin 271 151 3·46 0·01 0·05
Phloretin 273 167 3·44 0·05 0·2
Enterodiol 301 253 3·24 0·1 0·5
Enterolactone 297 107 3·50 0·01 0·02
Taxifolin (internal standard) 303 125 2·98 0·1 0·2
LOD, limits of detection; LOQ, limits of quantification.
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isorhamnetin, enterodiol and phloretin; 5–50mM for gallic and 4-
O-methylgallic acids, naringenin, and enterolactone; 0·5–50mM
for hesperetin. Peak areas were plotted against the corresponding
standard concentrations. A good linearity (r 2 0·986–0·999) was
observed in the range of concentrations observed for all urine
samples, except for hesperetin where a weighted 3rd polynominal
expression was used for calibration.
Standard samples for limits of detection and limits of quantifi-
cation were prepared by spiking blank urine samples over a con-
centration range of 0·01–10mM with ten different concentration
levels, and duplicate extractions and injections at each level.
Accuracy and intra- and inter-day assay precision
Accuracy and intra- and inter-day assay precision of the method
were determined by assaying six replicates of blank urine samples
spiked with solutions of the fifteen phenolic compounds at six
separate concentrations (1, 2, 5, 10, 20 and 50mM) over 6 d for
inter-day CV (reproducibility) and in six independent assays on
the same day for intra-day CV (repeatability). Accuracy was
measured as the percentage deviation from the added
concentrations.
Statistical analyses
Values are given as means with their standard errors. Paired com-
parisons between control and polyphenol-rich beverage intake
were performed for urinary concentrations of all polyphenols
and their metabolites by a non-parametric Mann–Whitney U test
(Excel statistics version 5·0; Esumi Co. Ltd, Tokyo, Japan). All of
the statistical tests were two-tailed.
Results
Validation of a high-throughput method for the analysis of
polyphenols in urine
Fifteen polyphenols (Fig. 1) were analysed by HPLC-ESI-MS-MS
analysis using a short reverse-phase column and multiple reaction
monitoring detection. They were selected for their abundance in
the human diet and in the beverages considered in the present
study, and for being representative of the main types of polyphe-
nol classes. A short solvent gradient was applied, which allowed
the analysis of all polyphenols within 6 min (Fig. 2). Typical
chromatograms of human urine samples collected after intake of
the polyphenol-rich beverages are shown in Fig. 3. Most extracted
traces showed a single peak for a given ion pair. Chromatograms
of blank urine samples showed only two main peaks in addition to
the internal standard (Fig. 3 (A)). One is enterolactone, not sig-
nificantly affected by the 2 d wash-out period.
The limits of detection (S/N . 3) and limits of quantification
(S/N . 10) were determined for all standards (Table 2). These
data indicated wide differences in sensitivity between polyphenols
and sufficient sensitivity to estimate them in urine samples.
Repeatability, reproducibility and accuracy were evaluated at
six different concentrations (Table 3). Accuracy varied
from 2 4·1 to 3·2 %, and intra- and inter-day variability were
lower than 10·1 and 10·3 % respectively. Thus, validation of
Fig. 1. Chemical structures of polyphenols and their metabolites analysed by the HPLC-electrospray-tandem mass spectrometry method.
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this method for estimation of sixteen polyphenols and their
metabolites in human urine was achieved.
Urinary excretion of polyphenols after consumption of
polyphenol-rich beverages
These fifteen polyphenols were estimated in urine samples col-
lected in the 24 h following the consumption of different polyphe-
nol-rich beverages. The composition of the beverages is given in
Table 1. Coffee, green tea, cocoa and grape-skin beverages were
ingested hot by nine volunteers at intervals of 2 weeks in a
random order. Consumption of instant coffee provided 259 mg
phenolic acids, green tea, 263 mg catechins, cocoa beverage,
289 mg catechins and proanthocyanidin, and the grape-skin-
extract beverage, 280 mg of different polyphenols including
267 mg malvidin 3-glucoside. Two citrus juices were also
tested, grapefruit and orange juice, providing respectively
252 mg (largely naringin) and 271 mg (largely hesperidin) flava-
none glycosides.
Large differences in the urinary excretion of the fifteen poly-
phenols were observed between beverages (Table 4). Enterolac-
tone and low amounts of caffeic acid, m-coumaric acid,
naringenin and enterodiol were observed in control urine samples.
Ingestion of the grape-skin extract and of coffee induced a signifi-
cant increase of the urinary excretion of caffeic acid. An increase
in the urinary excretion of m-coumaric acid, a microbial metab-
olite of caffeic acid and chlorogenic acid, was also observed
after coffee intake. Consumption of grape-skin extract and
green tea induced an increase of the urinary excretion of gallic
acid and its metabolite, 4-O-methylgallic acid. Epicatechin was
observed in green tea and cocoa urine samples. A high level of
naringenin and hesperetin urinary excretion was observed after
consuming grapefruit and orange juices respectively. Isorhamne-
tin and phloretin were also specifically detected after consumption
of citrus juices. Catechin and kaempferol could not be detected in
any of the urine samples. No significant difference in urinary
recovery could be observed between men and women for any
of the polyphenols analysed.
Discussion
Most often, analytical methods are developed to estimate poly-
phenols of specific types in urine or plasma samples. It is import-
ant, particularly for epidemiological studies in which the subjects
ingest a large variety of polyphenols with their regular diet, to be
able to simultaneously estimate the main polyphenols provided by
the different foods and beverages. In an earlier study, an HPLC-
APCI-MS method was developed to quantify twelve flavonoids in
human urine (Nielsen et al. 2000). However, the single ion moni-
toring mode used to detect the flavonoids required a proper sep-
aration of the different compounds and a run time of more than
90 min. In the present study, a rapid and selective method was
developed for the simultaneous quantification of fifteen polyphe-
nols including flavonoids, mammalian lignans, phenolic acids and
Fig. 2. Total ion chromatogram (TIC) and extracted single ion chromatograms of a mixture of fifteen dietary polyphenols (10mM) obtained by an HPLC-electro-
spray-tandem mass spectrometry method in multiple reaction monitoring mode with negative ionisation. IS, internal standard.
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phloretin. Detection with multiple reaction monitoring allowed us
to considerably shorten the run time to 6 min. Accuracy and pre-
cision were well within the limits recommended by the Food and
Drug Administration’s guidelines for bioanalytical method vali-
dation (US Department of Agriculture, 2001). Such a short run
time makes this method particularly adapted to the analysis of
large batches of samples as commonly found in epidemiological
studies.
Using this method, urinary excretion of the main polyphenols
consumed with six different polyphenol-rich beverages could be
measured. Beverages were selected for their high consumption
or for their content in specific flavonoids or phenolic acids repre-
sentative of the main types of dietary polyphenols (Table 1). Most
polyphenols are quickly excreted in the 24 h following their inges-
tion (Manach et al. 2004a,b). Their excretion in 24 h urine
samples should therefore be directly related to the amounts
ingested during the same and previous day.
Coffee is known to be a major dietary source of chlorogenic
acid (Clifford, 2000). Chlorogenic acid and caffeic acid were
the main phenolic compounds recovered in urine after coffee
intake (Table 4). No chlorogenic acid could be detected with
any of the other beverages. Some previous authors failed to
detect chlorogenic acid in either urine or plasma after ingestion
of chlorogenic acid or chlorogenic acid-containing food (Booth
et al. 1957; Bourne & Rice-Evans, 1998; Choudhury et al.
1999; Azuma et al. 2000; Nardini et al. 2002; Rechner et al.
2002). However, chlorogenic acid has been found in urine after
ingestion of pure chlorogenic acid or prunes (Cremin et al.
2001; Olthof et al. 2001, 2003; Gonthier et al. 2003c). After
ingestion of chlorogenic acid by healthy volunteers, a 1·7 %
Fig. 3. Typical extracted single ion chromatograms of human urine samples collected after consumption of various polyphenol-rich beverages obtained by an
HPLC-electrospray-tandem mass spectrometry method in multiple reaction monitoring mode with negative ionisation. (A), Blank urine sample; (B), green tea
intake urine; (C), grape-skin extract; (D), cocoa; (E), coffee; (F), grapefruit juice; (G), orange juice. For identity of the peaks, see Fig. 2.
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recovery of chlorogenic acid in urine was reported (Olthof et al.
2003). In the present study, consumption of coffee resulted in a
2·3 % recovery of chlorogenic acid in urine. Actual excretion
may still be higher. Indeed, when the same analytical method
was applied to a blank urine sample spiked with pure chlorogenic
acid, not only chlorogenic acid but also caffeic acid were
detected, showing that part of chlorogenic acid was hydrolysed
during sample processing (data not shown), most likely by
some esterase activity present in the H. pomatia enzyme mixture.
The higher concentration of caffeic acid in urine observed after
coffee consumption as compared with other beverage groups
(Table 4) can be explained by the hydrolysis of chlorogenic
acid by the microflora in the colon (Couteau et al. 2001; Gonthier
et al. 2003c), as well as by the deconjugating enzymes during pro-
cessing of urine samples. A significant increase of caffeic acid
urinary excretion was also observed after ingestion of the
grape-skin extract. Most probably caffeic acid originates from
caftaric acid, a caffeoyl tartrate ester present in grape (Gonthier
et al. 2003a). m-Coumaric acid was detected in all urine samples.
It is a known metabolite of caffeic acid (Gonthier et al. 2003c),
and in all samples it is present together with caffeic acid (Table
4). Expectedly, the highest concentrations were observed in
urine samples collected after coffee consumption.
Gallic acid was found together with its major 4-O-methylated
metabolite in urine samples collected after intake of green tea
or grape-skin extract (Table 4) (Shahrzad & Bitsch, 1998). 4-O-
Methylgallic acid was previously described as a major metabolite
of gallic acid identified in plasma after wine consumption (Cac-
cetta et al. 2000). Both account together for 29 % of the gallic
acid ingested with the grape-skin extract. A similarly high value
(36–40 %) was obtained after ingestion of pure gallic acid
(Shahrzad et al. 2001). Lower amounts of gallic acid and its
4-O-methylated metabolite were also excreted in urine after
green tea consumption (Table 4). Most probably they originate
from the hydrolysis of gallated catechins, as the content of free
gallic acid is very low in green tea as compared with the content
of gallated catechins (Del Rio et al. 2004). In the present study,
both gallic acid and its O-methylated metabolite accounted for
Table 3. Evaluation of precision and accuracy in the analysis of polyphenols and their metabolites in human urine by
HPLC-electrospray-tandem mass spectrometry
(Means of six measurements for all standards, and ranges)
Concentration (mM)
Found Accuracy (%)
Intra-day precision
(CV %)
Inter-day precision
(CV %)
Added Mean Range Mean Range Mean Range Mean Range
1 1·0 0·9 to 1·1 2·2 –6·4 to 8·2 10·1 3·2 to 21·8 10·3 4·0 to 19·6
2 2·0 1·7 to 2·2 –2·1 –13·6 to 10·1 6·8 2·5 to 12·1 6·7 4·7 to 9·8
5 4·8 4·2 to 5·1 24·1 –16·8 to 1·7 3·9 0·2 to 12·8 4·0 0·5 to 12·2
10 10·1 9·7 to 10·3 1·0 –2·7 to 3·0 3·5 2·1 to 5·9 4·3 3·6 to 5·3
20 20·6 20·0 to 21·0 3·2 –0·1 to 5·2 3·5 1·1 to 6·5 4·8 1·0 to 6·5
50 50·2 49·6 to 52·1 0·4 –0·7 to 4·2 2·5 0·2 to 10·6 2·5 0·7 to 8·3
Table 4. Urinary excretion of polyphenols and their metabolites after polyphenol-rich beverage intake by nine healthy volunteers
(Mean values with their standard errors)
Urinary excretion (mmol/24 h) Urinary excretion (mmol/6 h)
Control Green tea
Grape skin
extract Cocoa Coffee Grapefruit† Orange†
Compound Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Chlorogenic acid n.d. n.d. n.d. n.d. 5·3** 2·0 n.d. n.d.
Caffeic acid 0·1 0·2 0·3 0·5 0·7** 0·3 0·4 0·4 2·1** 0·5 0·4 0·2 0·2 0·1
m-Coumaric acid 0·5 0·9 1·2 1·3 0·8 1·0 1·4 1·4 2·6* 2·4 0·3 0·2 0·2 0·1
Gallic acid n.d. 0·3 0·8 5·9** 1·4 n.d. n.d. n.d. n.d.
4-O-Methylgallic acid n.d. 0·9 1·6 15·7** 2·8 0·6 1·1 n.d. n.d. n.d.
Catechin n.d. n.d. n.d. n.d. n.d. n.d. n.d.
Epicatechin n.d. 2·1 3·1 n.d. 4·3* 4·2 n.d. n.d. n.d.
Quercetin n.d. 0.1 0·2 n.d. n.d. n.d. n.d. n.d.
Isorhamnetin n.d. n.d. n.d. n.d. n.d. 0·1 0·1 0·3** 0·1
Kaempferol n.d. n.d. n.d. n.d. n.d. n.d. n.d.
Hesperetin n.d. 0·5 1·4 n.d. n.d. n.d. n.d. 16·6** 7·3
Naringenin 0·1 0·2 0·5* 0·5 0·3* 0·2 0·3 0·4 0·0 0·1 24·7** 12·6 8·4** 3·1
Phloretin n.d. n.d. n.d. n.d. n.d. 1·5 1·6 0·7 0·4
Enterodiol 0·5 1·1 0·2 0·3 1·0** 0·6 0·2 0·3 0·1 0·3 0·0 0·1 0·1 0·1
Enterolactone 3·8 2·8 3·0 3·3 6·7 4·8 3·6 2·9 2·8 2·0 1·4 1·4 1·8 1·1
n.d., Not detected.
Mean value was significantly different from control: * P,0·05, ** P,0·01.
†Urine collected between 6 and 12 h after juice intake.
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0·2 % of the gallic acid ingested as esters with catechins. This
suggests a low hydrolysis of tea galloyl esters in the body. A
low bioavailability of esters of gallic acid or cinnamic acids as
compared with the free acids has been reported previously (Hodg-
son et al. 2000; Adam et al. 2002).
Epicatechin was excreted in urine after green tea and cocoa
intake. The amounts recovered in urine accounted for 2·9 and
1·9 % of the epicatechin ingested with the green tea and cocoa
beverage respectively, values much lower than previously
reported after cocoa or chocolate consumption (25–30 %) (Baba
et al. 2000) but similar to that reported after ingestion of pure
catechin (1–3 %) (Goldberg et al. 2003). Catechin present in
lower amounts in the green tea and cocoa beverage was not
detected in urine due to its lower intake and low ionisation in
our experimental conditions (Table 2).
Quercetin was detected in low concentration in urine after
green tea consumption. Quercetin was not analysed in the green
tea extract used in the present study but green tea is known to
contain several quercetin glycosides (Del Rio et al. 2004). No
quercetin could be detected in urine samples collected after
intake of the other beverages, in agreement with the lower con-
centration or absence of quercetin in these beverages (Hertog
et al. 1993).
Naringenin was excreted in high concentration after ingestion
of grapefruit and orange juice, the main dietary source of flava-
nones. Urinary recovery of naringenin in the 6–12 h urine
samples accounted for 6·8 % (mol/mol) of the naringenin glyco-
sides ingested with grapefruit juice. Recovery of naringenin and
hesperetin accounted respectively for 12·9 and 4·3 % of the corre-
sponding glycosides ingested with orange juice. Excretion of fla-
vanones in this time period accounts for about two-thirds of the
total excretion over 24 h (C Manach and C Morand, unpublished
results). The present recovery figures are close to average values
(8·8 and 8·6 % for naringenin and hesperetin respectively) calcu-
lated from previously published data (Manach et al. 2004b).
A small amount of naringenin was also found in urine samples
after ingestion of the other beverages, suggesting that a 2 d wash-
out period was not sufficient to excrete all naringenin ingested
before the intervention period. The very high concentrations of
naringenin reached after citrus fruit ingestion as compared with
those of all other polyphenols ingested in similar quantities (see
Table 4) and the widespread consumption of orange juice most
probably explains the specific residual occurrence of naringenin
in these samples. Isorhamnetin, known as an O-methylated
metabolite of quercetin, but not quercetin itself, was also
found in urine after grapefruit and orange consumption. Its pre-
sence could derive from the presence of low amounts of quercetin
in these juices but it would not explain its absence in other
urine samples collected after consumption of other beverages
which may also contain low amounts of quercetin (Hertog et al.
1993).
Phloretin was detected in the urine samples collected after
consumption of both grapefruit and orange juice. This is the
first time that its presence is reported after consumption of
citrus juices. It can be assumed that phloretin was produced
from naringenin by reductive opening of the C-ring, since
phloretin corresponds to the dihydrochalcone form of narin-
genin. Naringenin has been shown to isomerise to naringenin
chalcone in simulated gut conditions (Gil-Izquierdo et al.
2003), which could be itself dihydrogenated to phloretin by
the gut microflora. The only foods containing phloretin are
apple and apple-derived products, and its use as a biomarker
of apple consumption has been suggested (DuPont et al.
2002). The present results raise some doubts about its possible
use as a biomarker of apple intake.
Enterolactone was detected in all urine samples including those
of the control group. Enterodiol, a metabolite of enterolactone,
was also present in most urine samples, although in lower concen-
trations. These lignans, also called mammalian lignans or entero-
lignans, are produced by the intestinal microflora. They have a
dietary origin but their exact precursors and food sources are
still a matter of debate (Heinonen et al. 2001; Begum et al.
2004). Intake of dietary fibre and fibre from grains has been
associated with enterolignan excretion (Adlercreutz et al. 1981,
1987; Lampe et al. 1999). Lignan excretion levels measured in
the present study were well within the range of previously pub-
lished values (Horn-Ross et al. 1997). They are not significantly
influenced by the consumption of beverages, suggesting that the
beverages considered in the present paper do not contain major
precursors of mammalian lignans. Mammalian lignans identified
in the control group are not easily washed out either, because
of a relatively slow elimination as compared with other polyphe-
nols, or because of the existence of unknown precursors still pre-
sent in the polyphenol-free diet consumed during the 2 d wash-out
period. The lower values for lignans in the citrus juice groups are
explained by the shorter period over which the urine samples
were collected.
Conclusion
We developed a rapid analytical method for the simultaneous
quantification of fifteen phenolic compounds in human urine
using HPLC-ESI-MS-MS. With a run time of 6 min, the
assay is faster than any other published method developed for
the simultaneous determination of various polyphenols in
urine samples. It is particularly adapted to the analysis of a
large series of urine samples, as required for epidemiological
studies. The results obtained in the present trial suggest that
compounds such as chlorogenic acid, gallic acid, epicatechin,
naringenin or hesperetin could be used as biomarkers to evalu-
ate the consumption of respectively coffee, wine, tea or cocoa,
and citrus juices. Validation is underway based on the analysis
of urine samples collected from 171 subjects following their
free-living diet (L Mennen, D Sapinho, H Ito, P Galan, S Herc-
berg and A Scalbert, unpublished results). This should help esti-
mate more precisely polyphenol intake or exposure, and to
determine, in epidemiological studies, optimal levels of poly-
phenol intake for better health.
Acknowledgements
This project received a grant from the French Ministry of
Research (AQS 02 P 0681 and AQS 02 P 0680). Special thanks
are addressed to Unilever Bestfoods France (UBF), to the
‘Centre d’Information Scientifique The´ & Sante´ de Lipton’,
UBF and to the Agence Pour la Recherche et l’Information en
Fruits et Le´gumes frais (APRIFEL, Paris) for their financial
support. H. I. is grateful to the Japanese Ministry of Education,
Culture, Sports, Science and Technology for a visiting researcher
grant. The authors also thank Unilever Research (Colworth, Beds,
UK), Nestle´ (Vevey, Switzerland), Masterfoods (Hackettstown,
Beverage intake and urinary polyphenols 507
NJ, USA) and CHR Hansen (Saint Julien de Peyrolas, France) for
respectively supplying the green tea extract, coffee powder, cocoa
powder and grape-skin extract, together with the corresponding
analytical data.
References
Adam A, Crespy V, Levrat-Verny MA, Leenhardt F, Leuillet M, Demigne
C & Re´me´sy C (2002) The bioavailability of ferulic acid is governed
primarily by the food matrix rather than its metabolism in intestine
and liver in rats. J Nutr 132, 1962–1968.
Adlercreutz H, Fotsis T, Heikkinen R, Dwyer JT, Goldin BR, Gorbach SL,
Lawson AM & Setchell KD (1981) Diet and urinary excretion of lig-
nans in female subjects. Med Biol 59, 259–261.
Adlercreutz H, Fotsis T, Heikkinen R, Dwyer JT, Woods M, Goldin BR &
Gorbach SL (1982) Excretion of the lignans enterolactone and entero-
diol and of equol in omnivorous and vegetarian postmenopausal women
and in women with breast cancer. Lancet ii, 1295–1299.
Adlercreutz H, Ho¨ckerstedt K, Bannwart C, Bloigu S, Hamalainen E,
Fotsis T & Ollus A (1987) Effect of dietary components, including lig-
nans and phytoestrogens, on enterohepatic circulation and liver metab-
olism of estrogens, and on sex hormone binding globulin (SHBG). J
Steroid Biochem 27, 1135–1144.
Akaza H, Miyanaga N, Takashima N, et al. (2002) Is daidzein non-meta-
bolizer a high risk for prostate cancer? A case-controlled study of
serum soybean isoflavone concentration. Jpn J Clin Oncol 32,
296–300.
Arts ICW & Hollman PCH (2005) Polyphenols and disease risk in epide-
miological studies. Am J Clin Nutr 81, Suppl. 1, 317S–325S.
Azuma K, Ippoushi K, Nakayama M, Ito H, Higashio H & Terao J (2000)
Absorption of chlorogenic acid and caffeic acid in rats after oral admin-
istration. J Agric Food Chem 48, 5496–5500.
Baba S, Osakabe N, Yasuda A, Natsume M, Takizawa T, Nakamura T &
Terao J (2000) Bioavailability of (-)-epicatechin upon intake of choco-
late and cocoa in human volunteers. Free Radic Res 33, 635–641.
Begum AN, Nicolle C, Mila I, Lapierre C, Nagano K, Fukushima K, Hei-
nonen SM, Adlercreutz H, Re´me´sy C & Scalbert A (2004) Dietary lig-
nins are precursors of mammalian lignans in rats. J Nutr 134, 120–127.
Booth AN, Emerson OH, Jones FT & DeEds F (1957) Urinary metabolites
of caffeic and chlorogenic acids. J Biol Chem 229, 51–59.
Bourne LC & Rice-Evans CA (1998) Urinary detection of hydroxycinna-
mates and flavonoids in humans after high dietary intake of fruit. Free
Radic Res 4, 429–438.
Caccetta RA-A, Croft KD, Beilin LJ & Puddey IB (2000) Ingestion of red
wine significantly increases plasma phenolic acid concentrations but
does not acutely affect ex vivo lipoprotein oxidizability. Am J Clin
Nutr 71, 67–74.
Choudhury R, Srai SK, Debnam E & Rice-Evans CA (1999) Urinary
excretion of hydroxycinnamates and flavonoids after oral and intrave-
nous administration. Free Radic Biol Med 27, 278–286.
Clifford MN (2000) Chlorogenic acids and other cinnamates - nature,
occurence and dietary burden. J Sci Food Agric 79, 362–372.
Couteau D, McCartney AL, Gibson GR, Williamson G & Faulds CB
(2001) Isolation and characterization of human colonic bacteria able
to hydrolyse chlorogenic acid. J Appl Microbiol 90, 873–881.
Cremin P, Kasim-Karakas S & Waterhouse AL (2001) Lc/es-ms detection
of hydroxycinnamates in human plasma and urine. J Agric Food Chem
49, 1747–1750.
Del Rio D, Stewart AJ, Mullen W, Burns J, Lean ME, Brighenti F &
Crozier A (2004) HPLC-MSn analysis of phenolic compounds and
purine alkaloids in green and black tea. J Agric Food Chem 52,
2807–2815.
DuPont MS, Bennett RN, Mellon FA & Williamson G (2002) Polyphenols
from alcoholic apple cider are absorbed, metabolized and excreted by
humans. J Nutr 132, 172–175.
Franke AA, Custer LJ, Wilkens LR, Le Marchand LL, Nomura AM,
Goodman MT & Kolonel LN (2002) Liquid chromatographic-photo-
diode array mass spectrometric analysis of dietary phytoestrogens
from human urine and blood. J Chromatogr, 777B, 45–59.
Gil-Izquierdo A, Gil MI, Tomas-Barberan FA & Ferreres F (2003) Influ-
ence of industrial processing on orange juice flavanone solubility and
transformation to chalcones under gastrointestinal conditions. J Agric
Food Chem 51, 3024–3028.
Goldberg DM, Yan J & Soleas GJ (2003) Absorption of three wine-related
polyphenols in three different matrices by healthy subjects. Clin Bio-
chem 36, 79–87.
Gonthier M-P, Cheynier V, Donovan JL, Manach C, Morand C, Mila I,
Lapierre C, Re´me´sy C & Scalbert A (2003a) Microbial aromatic acid
metabolites formed in the gut account for a major fraction of the poly-
phenols excreted in urine of rats fed red wine polyphenols. J Nutr 133,
461–467.
Gonthier M-P, Rios LY, Verny M-A, Re´me´sy C & Scalbert A (2003b) A
novel liquid chromatography-electrospray ionization mass spectrometry
method for the quantification in urine of microbial aromatic acid metab-
olites derived from dietary polyphenols. J Chromatogr 789B, 247–255.
Gonthier M-P, Verny MA, Besson C, Re´me´sy C & Scalbert A (2003c)
Chlorogenic acid bioavailability largely depends on its metabolism
by the gut microflora in rats. J Nutr 133, 1853–1859.
Gutteridge JMC & Halliwell B (1994) Antioxidants in Nutrition, Health,
and Disease. Oxford: Oxford University Press.
Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wahala K, Deyama T,
Nishibe S & Adlercreutz H (2001) In vitro metabolism of plant lignans:
new precursors of mammalian lignans enterolactone and enterodiol. J
Agric Food Chem 49, 3178–3186.
Hertog MGL, Hollman PCH & van de Putte B (1993) Content of poten-
tially anticarcinogenic flavonoids in tea infusions, wine and fruit
juices. J Agric Food Chem 41, 1242–1246.
Hodgson JM, Morton LW, Puddey IB, Beilin LJ & Croft KD (2000)
Gallic acid metabolites are markers of black tea intake in humans. J
Agric Food Chem 48, 2276–2280.
Horn-Ross PL, Barnes S, Kirk M, Coward L, Parsonnet J & Hiatt RA
(1997) Urinary phytoestrogen levels in young women from a multieth-
nic population. Cancer Epidemiol Biomarkers Prev 6, 339–345.
Hulten K, Winkvist A, Lenner P, Johansson R, Adlercreutz H & Hallmans
G (2002) An incident case-referent study on plasma enterolactone and
breast cancer risk. Eur J Nur 41, 168–176.
Kilkkinen A, Stumpf K, Pietinen P, Valsta LM, Tapanainen H &
Adlercreutz H (2001) Determinants of serum enterolactone concen-
tration. Am J Clin Nutr 73, 1094–1100.
Lampe JW, Gustafson DR, Hutchins AM, Martini MC, Li S, Wahala K,
Grandits GA, Potter JD & Slavin JL (1999) Urinary isoflavonoid and
lignan excretion on a Western diet: relation to soy, vegetable, and
fruit intake. Cancer Epidemiol Biomarkers Prev 8, 699–707.
Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C & Re´me´sy
C (2003) Bioavailability in humans of the flavanones hesperidin and
narirutin after the ingestion of two doses of orange juice. Eur J Clin
Nutr 57, 235–242.
Manach C, Scalbert A, Morand C, Re´me´sy C & Jimenez L (2004a) Poly-
phenols - food sources and bioavailability. Am J Clin Nutr 79,
727–747.
Manach C, Williamson G, Morand C, Scalbert A & Re´me´sy C (2004b)
Bioavailability and bioefficacy of polyphenols in humans -I- a review
of 97 bioavailability studies. Am J Clin Nutr 230S–242S.
Maskarinec G, Singh S, Meng L & Franke AA (1998) Dietary soy intake
and urinary isoflavone excretion among women from a multiethnic
population. Cancer Epidemiol Biomarkers Prev 7, 613–619.
Morand C, Manach C, Donovan JL & Re´me´sy C (2001) Preparation and
characterization of flavonoid metabolites present in biological samples.
Meth Enzymol 335, 115–121.
Nardini M, Cirillo E, Natella F & Scaccini C (2002) Absorption of phe-
nolic acids in humans after coffee consumption. J Agric Food Chem
50, 5735–5741.
H. Ito et al.508
Nielsen SE, Freese R, Cornett C & Dragsted LO (2000) Identification and
quantification of flavonoids in human urine samples by column-switch-
ing liquid chromatography coupled to atmospheric pressure chemical
ionization mass spectrometry. Anal Chem 72, 1503–1509.
Nielsen SE, Freese R, Kleemola P & Mutanen M (2002) Flavonoids in
human urine as biomarkers for intake of fruits and vegetables.
Cancer Epidemiol Biomarkers Prev 11, 459–466.
Olthof MR, Hollman PCH, Buijsman MNCP, van Amelsvoort JMM & Katan
MB (2003) Chlorogenic acid, quercetin-3-rutinoside and black tea phe-
nols are extensively metabolized in humans. J Nutr 133, 1806–1814.
Olthof MR, Hollman PCH & Katan MB (2001) Chlorogenic acid and caf-
feic acid are absorbed in humans. J Nutr 131, 66–71.
Rechner AR, Kuhnle G, Bremner P, Hubbard GP, Moore KP & Rice-
Evans CA (2002) The metabolic fate of dietary polyphenols in
humans. Free Radic Biol Med 33, 220–235.
Scalbert A, Manach C, Morand C, Re´me´sy C & Jime´nez L (2005) Dietary
polyphenols and the prevention of diseases. In Crit Rev Food Sci Nutr
45, 287–306.
Scalbert A & Williamson G (2000) Dietary intake and bioavailability of
polyphenols. J Nutr 130, 2073S–2085S.
Shahidi F & Naczk M (2003) Phenolics in Food and Nutraceuticals, 2nd
ed. Boca Raton, FL: CRC Press.
Shahrzad S, Aoyagi K, Winter A, Koyama A & Bitsch I (2001) Pharma-
cokinetics of gallic acid and its relative bioavailability from tea in
healthy humans. J Nutr 131, 1207–1210.
Shahrzad S & Bitsch I (1998) Determination of gallic acid and its metab-
olites in human plasma and urine by high-performance liquid chroma-
tography. J Chromatogr 705B, 87–95.
US Department of Agriculture, (2001) Guidance for industry: bioanalyti-
cal method validation. http://www.fda.gov/cder/guidance/4252fnl.htm
Beverage intake and urinary polyphenols 509
